# Establishing a Controlled Human Infection Model of Pertactin-deficient Bordetella Pertussis

> **NCT06827470** · PHASE1 · RECRUITING · sponsor: **Dalhousie University** · enrollment: 60 (estimated)

## Conditions studied

- Pertussis (Whooping Cough)

## Interventions

- **BIOLOGICAL:** Biological: Bordetella pertussis J820

## Key facts

- **NCT ID:** NCT06827470
- **Lead sponsor:** Dalhousie University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-24
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-04-30
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-12-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06827470

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06827470, "Establishing a Controlled Human Infection Model of Pertactin-deficient Bordetella Pertussis". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT06827470. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*